The clinical trial will assess the safety and effectiveness of a pulmonary vein isolation-only strategy to treat patients with persistent atrial fibrillation using the company’s Arctic Front Advance ...
Medtronic has secured not one but two new European approvals for its cardiac ablation devices to treat irregular heartbeats. That includes a CE mark for its PulseSelect pulsed field ablation system, a ...
Please provide your email address to receive an email when new articles are posted on . Medtronic announced it received expanded indication for its cardiac cryoablation focal catheters from the FDA ...
Medtronic plc MDT recently announced the receipt of the FDA’s expanded approval for Freezor and Freezor Xtra Cardiac Cryoablation. This approval is likely to bolster Medtronic’s cardiac Ablation ...
Summer may just be getting started, but Medtronic has colder temperatures on the brain. Much colder temperatures, in fact, with the FDA’s expanded clearance of the company’s cryoablation catheter to ...
Atrial fibrillation is the irregular and rapid beating of the upper two chambers of the heart (the atria). It may be classified as paroxysmal, persistent or permanent. It is the most common type of ...
A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding light on how to more effectively treat atrial fibrillation (AF) – a common heart rhythm problem ...
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM; “Adagio Medical”, “Adagio” or the “Company”), a leading innovator in catheter ablation technologies, today announced ...
A national study is shedding light on how to more effectively treat atrial fibrillation (AF) -- a common heart rhythm problem associated with increased risk of stroke and heart failure. The study ...
The catheter that Northern Virginia cardiologist Margaret H. Bell threaded into Johnathan Suthard's beating heart was as thin as a strand of linguini, its tip loaded with pressurized frozen nitrous ...
Boston Scientific (NYSE:BSX) has issued a correction recall for its POLARx and POLARx FIT cryoablation balloon catheters over concerns that they may cause serious esophageal injuries or even death.
Medtronic plc MDT announced the receipt of an expanded approval from the FDA for its Arctic Front Family of Cardiac Cryoablation Catheters to treat recurrent symptomatic paroxysmal atrial fibrillation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results